Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY: MRK )

72.20 USD -0.18 (-0.25%)
Streaming Delayed Price Updated: 4:40 AM EST, Mar 2, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 525
Open 72.38
Bid (Size) 72.15 (1)
Ask (Size) 72.56 (2)
Prev. Close 72.38
Today's Range 72.20 - 72.38
52wk Range 65.25 - 87.80
Shares Outstanding 2,690,303,898
Dividend Yield 2.66%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Merck Provides Update on KEYTRUDA® (pembrolizumab) Indication in Metastatic Small Cell Lung Cancer in the US
Merck Provides Update on KEYTRUDA® (pembrolizumab) Indication in Metastatic Small Cell Lung Cancer in the US 
From Business Wire News Releases
U.S. FDA Accepts Merck’s Gefapixant New Drug Application for Review
U.S. FDA Accepts Merck’s Gefapixant New Drug Application for Review 
From Business Wire News Releases

Performance

YTD
-10.82%
-10.82%
1 Month
-6.67%
-6.67%
3 Month
-10.19%
-10.19%
6 Month
-15.33%
-15.33%
1 Year
-11.27%
-11.27%

More News

Read More
Are These The Top Biotech Stocks To Buy In March? 4 Names To Consider
Tags Market News
From Stockmarket.com
SHAREHOLDER ALERT: WeissLaw LLP Investigates Pandion Therapeutics, Inc.
From PR Newswire
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Pandion Therapeutics, Inc. Buyout
From GlobeNewswire News Releases
Merck's Cough Drug Gefapixant Application Accepted For US Review
Tags MRK FDA Market News
From Benzinga
Warren Buffett Says Berkshire's Apple Investment Shows The 'Power Of Repurchases'
Tags BMY Benzinga AAPL
From Benzinga
Merck Animal Health Completes Acquisition of Poultry Sense Limited
From Business Wire News Releases
Biotech Stocks Can Provide Growth and Value in a Volatile Market
Tags Stocks / Equities ETFs Pharma/Biotech
From Blogs - TalkMarkets
PANDION THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Pandion Therapeutics, Inc. - PAND
From Business Wire News Releases
FDA Requires Additional Data On Merck COVID-19 Drug, EUA Moved Back
Tags News Health Care General
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.